Reference is made to the stock exchange notice announced by Hofseth Biocare ASA on 14 December regarding the notice for an extraordinary general meeting to be held at the offices of the Company at.
Reference is made to the stock exchange notice announced by Hofseth Biocare ASA on 13 December regarding an investment of NOK 144 million from Hofseth International AS into HBC subject to, among.